These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31567163)

  • 1. Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.
    Kendall EA; Durovni B; Martinson NA; Cavalacante S; Masonoke K; Saraceni V; Lebina L; Efron A; Cohn S; Chon S; Chaisson RE; Dowdy DW; Golub JE;
    AIDS; 2020 Jan; 34(1):63-71. PubMed ID: 31567163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial.
    Durovni B; Saraceni V; Moulton LH; Pacheco AG; Cavalcante SC; King BS; Cohn S; Efron A; Chaisson RE; Golub JE
    Lancet Infect Dis; 2013 Oct; 13(10):852-8. PubMed ID: 23954450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.
    Golub JE; Cohn S; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; Durovni B; Chaisson RE
    Clin Infect Dis; 2015 Feb; 60(4):639-45. PubMed ID: 25365974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.
    Jacobson KB; Niccolai L; Mtungwa N; Moll AP; Shenoi SV
    AIDS Care; 2017 Jul; 29(7):936-942. PubMed ID: 28147705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
    Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE
    BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.
    Grant AD; Charalambous S; Fielding KL; Day JH; Corbett EL; Chaisson RE; De Cock KM; Hayes RJ; Churchyard GJ
    JAMA; 2005 Jun; 293(22):2719-25. PubMed ID: 15941800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules.
    le Roux SM; Cotton MF; Golub JE; le Roux DM; Workman L; Zar HJ
    BMC Med; 2009 Nov; 7():67. PubMed ID: 19886982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial.
    Chamie G; Hahn JA; Kekibiina A; Emenyonu NI; Beesiga B; Marson K; Fatch R; Lodi S; Adong J; Thirumurthy H; McDonell MG; Gandhi M; Bryant K; Havlir DV; Kamya MR; Muyindike WR
    Lancet Glob Health; 2023 Dec; 11(12):e1899-e1910. PubMed ID: 37973340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and adherence to isoniazid preventive therapy among people living with HIV in multilevel health facilities in South-East, Nigeria: baseline findings from a quasi-experimental study.
    Akamike IC; Okedo-Alex IN; Agu AP; Alo C; Ogbonnaya LU
    Pan Afr Med J; 2020; 36():261. PubMed ID: 33014257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.
    Durovni B; Cavalcante SC; Saraceni V; Vellozo V; Israel G; King BS; Cohn S; Efron A; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
    AIDS; 2010 Nov; 24 Suppl 5(Suppl 5):S49-56. PubMed ID: 21079428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
    Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
    AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
    Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
    BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
    Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
    Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?
    Churchyard GJ; Fielding K; Charalambous S; Day JH; Corbett EL; Hayes RJ; Chaisson RE; De Cock KM; Samb B; Grant AD
    AIDS; 2003 Sep; 17(14):2063-70. PubMed ID: 14502009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
    Yanes-Lane M; Ortiz-Brizuela E; Campbell JR; Benedetti A; Churchyard G; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003738. PubMed ID: 34520459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.
    Churchyard G; Cárdenas V; Chihota V; Mngadi K; Sebe M; Brumskine W; Martinson N; Yimer G; Wang SH; Garcia-Basteiro AL; Nguenha D; Masilela L; Waggie Z; van den Hof S; Charalambous S; Cobelens F; Chaisson RE; Grant AD; Fielding KL;
    Ann Intern Med; 2021 Oct; 174(10):1367-1376. PubMed ID: 34424730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006.
    Mosimaneotsile B; Mathoma A; Chengeta B; Nyirenda S; Agizew TB; Tedla Z; Motsamai OI; Kilmarx PH; Wells CD; Samandari T
    J Acquir Immune Defic Syndr; 2010 May; 54(1):71-7. PubMed ID: 19934764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
    Golub JE; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; King BS; Efron A; Moore RD; Chaisson RE; Durovni B
    AIDS; 2007 Jul; 21(11):1441-8. PubMed ID: 17589190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia.
    Ayele HT; van Mourik MS; Bonten MJ
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1342-1347. PubMed ID: 27725045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.